Source comparison
CJC-1295 No DAC Dose Response Research: Protocol Comparison
50mcg once daily 12% 4.1 2–3 hours 22% Below threshold for meaningful receptor activation. Minimal IGF-1 response suggests this dose is suboptimal for most research applications 100mcg once daily 24% 8.2 4–5 hours 19% Produces measurable GH pulse and moderate
This comparison does not assign a generated winner or score.
- 50mcg once daily
- 12%
- 4.1
- 2–3 hours
- 22%
- Below threshold for meaningful receptor activation. Minimal IGF-1 response suggests this dose is suboptimal for most research applications
- 100mcg once daily
- 24%
- 8.2
- 4–5 hours
- 19%
- Produces measurable GH pulse and moderate IGF-1 elevation. Suitable for single-dose protocols but leaves 12–16 hour gaps between pulses
- 100mcg twice daily
- 41%
- 8.4 (per dose)
- 4–5 hours per dose
- 18%
- Highest sustained IGF-1 elevation with lowest variability. Twice-daily dosing maintains receptor availability and avoids prolonged somatostatin suppression
- 200mcg once daily
- 28%
- 11.4
- 5–6 hours
- 34%
- Higher peak GH but lower overall IGF-1 AUC due to receptor saturation and negative feedback. Increased variability makes outcomes less predictable